Their flagship product, a psorisis laser was FDA approved in July 2020 and should be saleable now. I would think it should generate alot of interest and time will tell for sure..
Based on the last filing, they also still have a pending deal for the stealthmark business to be sold for cash and stock in another business. Still being disclosed as pending..
Other than that, the share count has been respectable at just over 100M outstanding. Dilution has been kept very minimal for a long time.
It would really be great if we could get a strategic update from management. If they gain any traction you could see a big pop here, especially now that their medical device has been FDA approved and it's been under the radar so far. No eyes on it yet..
News 
Market Data 
Discover 
